Immunize.org supports evidence-based vaccination recommendations and schedules. Read more at About Us.

Clinical Resources: Seasonal Vaccines (Influenza, RSV, COVID)

Results (24)

Standing Orders for Administering Nirsevimab RSV Preventive Antibody (Beyfortus, by Sanofi) to Infants and High-Risk Young Children

Eligible healthcare professionals may vaccinate all infants and high-risk young children who meet the criteria established by the American Academy of Pediatrics (AAP) in September 2026 (https://doi.org/10.1542/peds.2026-079047), for immunization with a long-acting preventive antibody against RSV (nirsevimab, brand name Beyfortus, by Sanofi), with information provided on current CDC recommendations.

#P3097
Updated on: 9/14/26
Language: English

Declination of Influenza Vaccination

Form for healthcare worker signature and date, lists important reasons for annual influenza vaccination and consequences of vaccine refusal

#P4068
Updated on: 8/28/26
Language: English

Communicating the Benefits of Influenza Vaccination

Co-branded with AIM (Association of Immunization Managers), this one-page document presents science-based benefits of influenza (flu) vaccination and includes tips on communicating with patients.

#P3115
Updated on: 8/18/26
Language: English

Standing Orders for Administering 2025-2026 Formula Adjuvanted Protein COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer Nuvaxovid (Sanofi-Novavax) COVID-19 vaccine to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3141
Updated on: 11/13/25
Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Children 6 Months through 11 Years

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to children 6 months through 11 years, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, and IDSA are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140a
Updated on: 11/13/25
Language: English

Standing Orders for Administering 2025-2026 Formula mRNA COVID-19 Vaccine to Individuals 12 Years and Older

Eligible healthcare professionals may administer mRNA COVID-19 vaccines to individuals 12 years of age and older, following clinical guidance from CDC (Interim Clinical Considerations for Use of COVID-19 Vaccines). A list of high-risk conditions supported by evidence is provided, along with a list of conditions that should trigger use of the dosing schedule for people with moderate or severe immunocompromise. CDC recommends COVID-19 vaccination of any person age 6 months or older following a shared clinical decision-making discussion. Links to current COVID-19 vaccine recommendations from AAP, AAFP, IDSA, and ACOG are also provided. These organizations recommend routine vaccination for designated people at increased risk of infection or severe disease and shared clinical decision-making for those at lower risk.

#P3140
Updated on: 11/13/25
Language: English

Partner Resources

American Medical Association (AMA)

AMA's one-stop shop for respiratory virus vaccination recommendations from the American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP), American College of Obstetricians and Gynecologists (ACOG), and Infectious Diseases Society of America (IDSA) for the 2026-27 season.

Centers for Disease Control & Prevention

LetsGetRealAboutVaccines.org

Immunization science and safety for pediatric vaccines are explained in clear, plain language. In addition, the website uses visual communication to enhance accessibility and understanding. LetsGetRealAboutVaccines.org is an affiliate website of Immunize.org. The entire website is also a vailable in Spanish. Resources are appropriate for sharing with patients. Quick links to seasonal vaccination information:

VaccineInformation.org

Science-based content covering topics of vaccination during the entire lifespan, an overview of vaccine basics, and vaccine-preventable disease information. VaccineInformation.org is an affiliate website of Immunize.org. Resources are appropriate for sharing with patients. Quick links to seasonal vaccination information:

This page was updated on .